Pursuant to Regulation 29 and 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Pharmaids Pharmaceuticals has informed that the Board of Directors of the Company is scheduled to be held Monday, May 24, 2021 to consider the following business: Approval of audited financial results for the quarter and year ended 31.03.2021 and any Other matter with the permission of the Chair. Further, in accordance with its letter dated 31st March, 2021 the Trading window shall remain closed till 48 hours after communication of aforesaid Financial Results to the Stock Exchange.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.00 |
| Dr. Reddys Lab | 1222.65 |
| Cipla | 1229.95 |
| Zydus Lifesciences | 931.80 |
| Lupin | 2323.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: